Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors

Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors

US Patent 8058252 · Granted Nov 15, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for assessing the response to PD-1/PDL-1 targeting drugs2022
Immunogenic preprocalcitonin peptides2021
Method for assessing the response to PD-1/PDL-1 targeting drugs2021
Prostate cancer cell lines and their use in screening method2014
Preprocalcitonin antigen T epitopes2013
Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy2005